CD8+ T cells are a specialized class of immune cell whose primary job is to find and destroy body cells that have been infected by viruses, taken over by cancer, or otherwise gone wrong. They are often called “cytotoxic T lymphocytes” or “killer T cells” because they can directly execute compromised cells, something most other immune cells cannot do. Their importance stretches from everyday virus clearance to the frontiers of cancer immunotherapy, and understanding how they work reveals why some infections resolve quickly, why some cancers evade the immune system, and why your immune defenses weaken with age.
Where CD8+ T Cells Come From
All T cells, including CD8+ cells, originate from precursors in the bone marrow but mature in the thymus, a small organ behind the breastbone that is most active during childhood. Inside the thymus, immature T cells undergo a quality-control process called positive selection, which takes roughly three to four days. During that window, developing cells must prove they can recognize the body’s own tissue-identification molecules (called MHC class I molecules) well enough to be useful but not so aggressively that they would attack healthy tissue.1PubMed Central. Distinct phases in the positive selection of CD8+ T cells distinguished by intrathymic migration and T-cell receptor signaling patterns Cells that fail either test are eliminated. Only a small fraction survive and leave the thymus as mature, naive CD8+ T cells circulating through the blood and lymph nodes, waiting to encounter a threat they are built to recognize.
How They Recognize Threats
Nearly every nucleated cell in your body displays fragments of whatever proteins it is making on its surface, mounted on MHC class I molecules. Think of these as tiny display trays showing the cell’s internal contents to passing immune cells. A healthy cell displays normal self-protein fragments, which CD8+ T cells ignore. But if a virus has hijacked the cell, viral protein fragments appear on those trays instead. The discovery in 1974 that T cells require both the foreign fragment and the host’s own MHC molecule to activate, a principle called MHC restriction, earned Rolf Zinkernagel and Peter Doherty the Nobel Prize and fundamentally reshaped immunology.2PubMed Central. Rules of engagement: the discovery of MHC restriction
This dual-recognition system is remarkably specific. Each CD8+ T cell carries a unique receptor on its surface that fits one particular combination of MHC molecule and protein fragment. Your body generates millions of T cells with slightly different receptors, creating a vast library of possible matches. When one finds its match on an infected or abnormal cell, activation begins. Dendritic cells, a type of professional antigen-presenting cell, play a key role in kick-starting this process. They can even acquire MHC-loaded fragments from other cells and present them to CD8+ T cells, a process sometimes called cross-dressing, which is particularly relevant in priming anti-tumor immune responses.3Immunity. Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing
How They Kill
Once activated, a CD8+ T cell locks onto its target and deploys one of two main killing strategies. The faster and more common route involves releasing tiny packets called cytotoxic granules directly onto the target cell’s surface. These granules contain perforin, a protein that punches holes in the target’s membrane, and granzymes, a family of enzymes that enter through those holes and trigger the cell to self-destruct through programmed cell death.4PubMed Central. Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity The granule pathway is the defining feature of cytotoxic CD8+ T cells, and both the amount of perforin and the specific mix of granzymes a cell carries change as it matures and differentiates.5PubMed Central. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure
The second route uses a surface protein called Fas ligand. When a CD8+ T cell displays Fas ligand and the target cell carries the matching Fas receptor, the interaction triggers cell death in the target without requiring granules at all. This pathway turns out to be especially important in specific tissues. In the nervous system, for example, virus-specific CD8+ T cells kill infected neurons primarily through the Fas pathway rather than the perforin pathway.6European Journal of Immunology. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway Interestingly, Fas ligand is not a one-way weapon: it can also send signals back into the CD8+ T cell itself, promoting its own proliferation.7PubMed. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells
Fighting Viral Infections
The most familiar role of CD8+ T cells is clearing virus-infected cells, and their speed and strength directly affect how quickly you recover. Mathematical modeling of influenza infection, supported by clinical data from hospitalized H7N9 patients, shows a strong exponential relationship between the number of effector CD8+ T cells a person mounts and how long it takes to recover. Even modest increases in CD8+ T cell numbers can substantially shorten illness, which is a key argument for vaccines and strategies that build immunological memory.8PubMed Central. On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection
CD8+ T cells are also essential for clearing hepatitis B virus during acute infection. Studies in animal models have shown that they act as the main effector cells responsible for both viral clearance and the liver inflammation that accompanies it, using a mix of direct cell killing and non-killing antiviral mechanisms such as releasing cytokines that suppress viral replication without destroying the host cell.9PubMed Central. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection That dual nature, protection and tissue damage in the same package, is a recurring theme. A delayed CD8+ T cell response can sometimes lead to better viral clearance overall because the virus has time to spread more widely and recruit a larger immune response, but the trade-off is greater tissue damage during the acute phase.10Royal Society Open Science. Timing of CD8 T cell effector responses in viral infections
Memory Cells and Long-Term Protection
After an infection is cleared, most of the effector CD8+ T cells die off. But a small fraction survive and convert into memory T cells, which persist for years or even decades. These memory cells are the reason you rarely get the same viral illness twice with equal severity. Some circulate in the blood and lymph nodes, while others embed themselves in the tissues where the original infection occurred. These tissue-resident memory cells, often abbreviated as TRM cells, sit at barrier sites like the skin, lungs, and gut, acting as sentinels.
Research in mouse skin has shown that when tissue-resident memory CD8+ T cells detect a returning pathogen, they do not just kill infected cells. They trigger a broad alarm, switching on antiviral and antibacterial genes across the entire tissue. This “pathogen alert” can even protect against unrelated pathogens that the T cells were never specifically trained to fight.11PubMed. T cell memory. Skin-resident memory CD8⁺ T cells trigger a state of tissue-wide pathogen alert And these populations can be boosted after the fact. Repeated topical application of an antigen to skin expanded the local pool of antigen-specific tissue-resident memory CD8+ T cells by roughly 15-fold and significantly increased antiviral protection.12PubMed Central. Targeted Expansion of Tissue-Resident CD8+ T Cells to Boost Cellular Immunity in the Skin That finding has clear implications for vaccine design, which I will return to below.
CD8+ T Cells and Cancer
Tumors are not infections, but they share a critical vulnerability: cancer cells produce abnormal proteins that can be displayed on MHC class I molecules, marking them as targets. CD8+ T cells that infiltrate a tumor, often called tumor-infiltrating lymphocytes, are among the most important immune cells in cancer defense. High levels of CD8+ T cell infiltration are associated with better prognosis across many cancer types.13PubMed Central. New insights on anti-tumor immunity of CD8 + T cells: cancer stem cells, tumor immune microenvironment and immunotherapy Getting CD8+ T cells into the tumor in sufficient numbers is, in fact, one of the critical factors that determines whether immune checkpoint therapy will work.14Trends in Immunology. CD8+ T Cells: What They Are & Why They Matter
The problem is that tumors fight back. The tumor microenvironment is often low in oxygen and nutrients, high in immune-suppressing signals, and studded with checkpoint molecules that tell CD8+ T cells to stand down. Over time, CD8+ T cells exposed to this hostile environment become “exhausted,” gradually losing their ability to kill and to multiply. Blocking inhibitory checkpoint receptors like PD-1 and CTLA-4 with drugs called immune checkpoint inhibitors can reactivate these exhausted T cells and restore their anti-tumor activity, which is the principle behind drugs like pembrolizumab and nivolumab.15Cancer Biology & Medicine. The mechanisms and clinical significance of CD8+ T cell exhaustion in anti-tumor immunity
Recent research has uncovered more about what drives exhaustion at a molecular level. One study found that an oxidative stress response pathway involving a protein called NRF2, which normally protects cells from damage, paradoxically accelerates terminal exhaustion in CD8+ T cells fighting chronic infections or tumors. The pathway does this partly through a receptor called PTGIR, and silencing that receptor restored anti-tumor function in mice.16PubMed Central. NRF2-dependent regulation of the prostacyclin receptor PTGIR drives CD8 T cell exhaustion Findings like these point toward future combination strategies that address exhaustion alongside checkpoint blockade.
The Role of CD4+ Helper T Cells
CD8+ T cells do not work alone. They depend heavily on help from CD4+ T cells, a related but distinct class of immune cell. During acute infections and vaccination, CD4+ T cell help is important for the development of robust CD8+ T cell memory.17PubMed Central. The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer Without adequate CD4+ support, CD8+ T cells can still mount an initial response, but they tend to form weaker memory populations and become dysfunctional faster during prolonged challenges like chronic infections or cancer.
This dependency has therapeutic implications. Research has shown that a particular subset of highly cytotoxic CD8+ T cells, capable of controlling both chronic viral infections and tumors, depends on CD4+ T cell help delivered through the signaling molecule IL-21. Boosting this pathway experimentally enhanced the killer function of CD8+ T cells that had infiltrated tumors.18PubMed Central. CD4(+) T Cell Help Is Required for the Formation of a Cytolytic CD8(+) T Cell Subset that Protects against Chronic Infection and Cancer The takeaway for immunotherapy and vaccine design is that activating CD8+ T cells alone may not be enough; engaging CD4+ T cells simultaneously tends to produce stronger and longer-lasting protection.
When CD8+ T Cells Attack Your Own Body
The same killing power that makes CD8+ T cells effective against infections and cancer can cause serious harm when directed at healthy tissue. In type 1 diabetes, autoreactive CD8+ T cells are the primary agents that destroy insulin-producing beta cells in the pancreas.19PubMed Central. Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection Recent work has shown that this destruction is not contained to the cells directly attacked: when CD8+ T cells kill beta cells, the dying cells release inflammatory signals that cause neighboring, still-healthy beta cells to become dysfunctional as well, amplifying the damage beyond the initial immune assault.20Diabetes. Killing of Human β-Cells by CD8+ T Cells Triggers Inflammatory Paracrine Signaling and Neighboring β-Cell Dysfunction
Vitiligo, the skin condition that causes patches of depigmentation, is another clear example. It is driven by autoreactive CD8+ T cells that target melanocytes, the cells responsible for skin pigment.21PubMed Central. The Role of Memory CD8+ T Cells in Vitiligo Studies in both humans and animal models have traced the mechanism in detail: oxidative stress in skin cells causes them to release a chemical signal, CXCL16, that actively recruits CD8+ T cells to the skin, where they destroy melanocytes.22PubMed. Oxidative stress drives CD8(+) T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes In mouse models, the degree of skin depigmentation correlates directly with the number of melanocyte-specific CD8+ T cells present.23PubMed Central. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo These autoimmune examples illustrate a fundamental tension in immunology: the same precision and lethality that protect you from disease can be catastrophic when the targeting goes wrong.
Aging and Declining CD8+ T Cell Performance
One of the most visible consequences of aging on the immune system is the deterioration of CD8+ T cell function. As you get older, the thymus shrinks and produces fewer new naive T cells, which means the pool of cells available to respond to novel threats gradually narrows. At the same time, existing memory CD8+ T cells accumulate features of replicative senescence: they lose the ability to divide, stop expressing certain surface proteins needed for activation (like CD28), and begin secreting inflammatory molecules at higher rates. A large fraction of these senescent cells are specific for cytomegalovirus, a common herpesvirus that most people carry silently, and their expansion progressively crowds out diversity in the T cell repertoire.24PubMed Central. Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence
Animal studies confirm these age-related declines in practical terms. Aged mice infected with viruses like lymphocytic choriomeningitis virus or influenza mount weaker CD8+ T cell responses: fewer virus-specific cells are generated, fewer produce the key cytokine interferon-gamma, and the peak of the response is delayed compared to young animals.25Trends in Immunology. T-cell immunosenescence: lessons learned from mouse models of aging Whether these declines are intrinsic to the aged T cells themselves, a result of weaker CD4+ help, or both, remains an active question. But the clinical reality is clear: older adults are more vulnerable to severe outcomes from respiratory viruses and respond less robustly to vaccination, in significant part because their CD8+ T cell compartment is compromised.
Implications for Vaccine Design
Most vaccines in widespread use today were designed primarily to generate antibodies, and they do that well. Generating strong CD8+ T cell memory through vaccination has proven more complicated.26PubMed Central. Immunologic considerations for generating memory CD8 T cells through vaccination This matters because antibodies are good at blocking a pathogen before it enters cells, but once a virus is inside a cell, antibodies can no longer reach it. CD8+ T cells are what clean up cells that are already infected. For respiratory viruses in particular, injectable vaccines tend to generate CD8+ T cells that circulate in the blood but do not necessarily establish tissue-resident populations in the lungs, where the virus actually replicates. Mucosal immunization, delivering the vaccine directly to the airways or other mucosal surfaces, may be necessary to seed the tissue-resident memory cells that provide optimal local protection.27PubMed Central. Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses
This is an area of active research, especially after COVID-19 highlighted the limitations of injectable vaccines in preventing upper-airway infection. Several groups are developing nasal-spray or inhaled vaccine platforms aimed at building CD8+ T cell populations right at the site of viral entry. The underlying principle is that having sentinels stationed at the gates is more effective than having reinforcements that need to be mobilized from elsewhere in the body.
How Pathogens Evade CD8+ T Cell Surveillance
Given how lethal CD8+ T cells are, it is not surprising that many pathogens have evolved ways to dodge them. The most common tactic is to interfere with the MHC class I display system. If a virus can prevent its protein fragments from reaching the cell surface, CD8+ T cells have nothing to recognize, and the infected cell becomes invisible. Influenza A and B viruses both downregulate MHC class I molecules on the surfaces of infected cells, which delays CD8+ T cell recognition and buys the virus more time to replicate.28PubMed Central. Downregulation of MHC Class I Expression by Influenza A and B Viruses
SARS-CoV-2 uses a related but distinct strategy. Rather than directly stripping MHC molecules from the cell surface, it targets the signaling pathway that normally turns on MHC class I gene expression, specifically a regulatory axis involving STAT1, IRF1, and NLRC5. By suppressing this pathway, the virus reduces MHC class I levels from the inside out.29Nature Communications. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis These evasion mechanisms help explain why some viral infections become chronic or why initial immune responses are sometimes sluggish: the virus is actively sabotaging the detection system that CD8+ T cells rely on.
What Fuels a CD8+ T Cell
A resting naive CD8+ T cell is metabolically quiet, relying mainly on oxidative phosphorylation, which is the energy-efficient process cells use when there is no urgent demand. When it activates and begins dividing rapidly to fight an infection, the cell undergoes a dramatic metabolic shift, ramping up glycolysis and producing large amounts of lactic acid, even when oxygen is plentiful.30PubMed Central. Metabolic Dynamics of In Vitro CD8+ T Cell Activation This switch trades energy efficiency for speed, generating the raw materials needed for rapid cell division and protein production.
Once the threat is resolved and a cell transitions into the memory phase, it is often said to return to a fat-burning metabolic profile, relying on fatty acid oxidation. This idea has been influential in immunology, but more recent work using genetic rather than chemical tools to probe the question has challenged it. Genetic deletion of CPT1A, the enzyme thought to be essential for long-chain fatty acid oxidation in T cells, turned out not to impair memory CD8+ T cell development or protective immunity, suggesting the metabolic requirements for memory formation are more flexible than textbook models imply.31PubMed Central. Fatty acid metabolism in CD8(+) T cell memory: Challenging current concepts The practical significance is that efforts to manipulate T cell metabolism therapeutically, for example to improve vaccine responses or enhance anti-tumor immunity, may need to target multiple metabolic pathways rather than a single “memory switch.”